Jonathan McNeill

Chief Operating Officer and President

COO Other Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Dyne Therapeutics, Inc. (DYN)	Chief Business Officer	$430,468	—	$1,046,199	$522,287	$230,880	$996	$2,230,830

2026 Jefferies Global Healthcare Conference
Crescent Biopharma, Inc. (CBIO)

2026-06-03